Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.5300
+0.1739 (48.83%)
At close: Feb 20, 2026, 4:00 PM EST
0.5260
-0.0040 (-0.75%)
After-hours: Feb 20, 2026, 7:59 PM EST
Mangoceuticals Revenue
Mangoceuticals had revenue of $84.25K in the quarter ending September 30, 2025, a decrease of -36.83%. This brings the company's revenue in the last twelve months to $466.91K, down -38.16% year-over-year. In the year 2024, Mangoceuticals had annual revenue of $615.87K, down -15.81%.
Revenue (ttm)
$466.91K
Revenue Growth
-38.16%
P/S Ratio
17.47
Revenue / Employee
$155,636
Employees
3
Market Cap
8.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 615.87K | -115.62K | -15.81% |
| Dec 31, 2023 | 731.49K | 722.55K | 8,083.16% |
| Dec 31, 2022 | 8.94K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGRX News
- 1 day ago - Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally? - Benzinga
- 1 day ago - Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model - Benzinga
- 2 days ago - MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program - GlobeNewsWire
- 2 months ago - Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements - GlobeNewsWire
- 2 months ago - Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy - GlobeNewsWire
- 2 months ago - Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs - GlobeNewsWire
- 3 months ago - Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs - Reuters